Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,418 | -10,835 | -4,319 | -4,345 | -2,193 |
| Depreciation Amortization | 11 | 25 | 14 | 4 | 0 |
| Income taxes - deferred | N/A | -389 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -303 | 1,125 | 469 | 510 | 1,172 |
| Other Working Capital | -1,064 | -3,270 | -2,916 | -2,589 | -931 |
| Other Operating Activity | 613 | 3,383 | -1,029 | -87 | -752 |
| Operating Cash Flow | $-3,161 | $-9,961 | $-7,781 | $-6,508 | $-2,704 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -111 | -33 | -32 | N/A |
| Purchase Of Investment | 0 | -8,176 | -8,176 | -8,176 | -3,619 |
| Sale Of Investment | 5,406 | 22,713 | 17,286 | 11,545 | 6,292 |
| Investing Cash Flow | $5,401 | $14,427 | $9,078 | $3,337 | $2,673 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 2,750 | N/A | N/A | N/A |
| Debt Issued | N/A | N/A | 2,750 | N/A | N/A |
| Debt Repayment | N/A | N/A | -2,750 | N/A | N/A |
| Common Stock Issued | 0 | 266 | 265 | 265 | 0 |
| Other Financing Activity | -1 | -2,750 | 0 | 0 | 0 |
| Financing Cash Flow | $-1 | $266 | $265 | $265 | $0 |
| Exchange Rate Effect | 20 | 174 | 155 | 142 | 10 |
| Beginning Cash Position | 8,701 | 3,796 | 3,796 | 3,796 | 3,796 |
| End Cash Position | 10,960 | 8,701 | 5,513 | 1,033 | 3,775 |
| Net Cash Flow | $2,259 | $4,905 | $1,717 | $-2,764 | $-21 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,161 | -9,961 | -7,781 | -6,508 | -2,704 |
| Capital Expenditure | -5 | -111 | -33 | -32 | 0 |
| Free Cash Flow | -3,166 | -10,072 | -7,813 | -6,540 | -2,704 |